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Cyclooxygenase-2  
and prorenin receptor 
in the macula densa
It would seem that we know everything 
about the role of renin in the control 
of renal circulation. However, recent 
studies have identifi ed a membrane-
bound receptor for renin and prorenin 
that is capable of signaling. But what are 
the downstream targets of the signaling? 
Th is is a particularly interesting 
question because it seems that patients 
with diabetes mellitus have high 
prorenin levels (but low renin levels). In 
this issue, Kaneshiro et al. explore this 
question and fi nd that cyclooxygenase-
2 (COX-2) is one such target. COX-2 
is expressed specifi cally in the macula 
densa cells, whereas COX-1 is more 
ubiquitously expressed. Th ere is 
strong evidence that nonsteroidal 
anti-infl ammatory drugs produce 
salt retention, decreased glomerular 
fi ltration rate, and changes in the 
renin–angiotensin system because of 
inhibition of COX-2. When the authors 
produced rats transgenic for the human 
prorenin receptor, these animals had 
higher levels of COX-2 in the macula 
densa cells; that is, more cells were 
stained for COX-2 protein than in non-
transgenic rats. Interestingly, there were 
no diff erences between the two groups 
in arterial urinary sodium excretion, 
or renal levels of the rat prorenin 
receptor mRNA. Inhibition of COX-2 
by a specifi c inhibitor decreased renal 
cortical blood fl ow in transgenic but not 
in wild-type rats. Th ese results suggest 
that COX-2 expression is under the 
control of the prorenin receptor. 
An informative Commentary by 
Nguyen sets this work in perspective. 
See page 618 and page 641.
Thrombopathies in 
vascular sclerosis
Vascular sclerosis, a common 
fi nding in renal biopsies, is seen in 
hypertension diabetes and a variety of 
other diseases. Although the causes 
of these anomalies remain obscure, 
endothelial damage has been identifi ed 
as a major source of pathology. One 
obvious cause of endothelial damage is 
inherited diseases such as mutations in 
the factor V gene, or prothrombin or 
methylenetetrahydrofolate reductase 
(MTHFR) gene mutations. Goforth 
et al. studied renal biopsies that 
showed vascular lesions and tested 
the patients for the above-mentioned 
gene mutations. Patients who had 
diabetes or hypertension or were heavy 
smokers did not have a signifi cant 
incidence of the mutations in factor V 
(the Leiden mutation) or prothrombin 
(G20210A) or have the polymorphism 
in the MTHFR gene that seems to 
correlate with endothelial damage. But 
17 biopsies in patients with vascular 
sclerosis of unknown etiology without 
diabetes hypertension or smokers 
showed a signifi cant incidence of these 
mutations. Th ree had the prothrombin 
G20210A mutation, two had the 
factor V Leiden mutation, and fi ve 
were homozygous for the MTHFR 
C677T polymorphism. When the 
data were evaluated as a whole, ten 
mutations were found in 17 patients. 
Eight of the 17 patients were observed 
to have at least one of the three forms 
of inherited thrombophilia. Th ese 
results demonstrate that almost 50% 
of the idiopathic vascular lesions were 
probably due to identifi able genetic 
factors. See page 743.
Low glomerular 
filtration rate in the 
population
Chronic kidney disease is best treated 
early in its course before the onset of 
widespread fi brosis. Th is puts a great 
emphasis on identifi cation of patients 
with early and likely asymptomatic 
renal disease. But the incidence of 
abnormalities in renal function is 
unknown, making it diffi  cult to identify 
the disease early in its development. In 
a study reported in this issue, Cirillo et 
al. attempted to rectify this challenge 
by examining the population of the 
medieval town of Gubbio in Umbria 
in central Italy. Th is group of 5000 
people has been well studied for a 
variety of diseases, and their response 
rates to questionnaires and medical 
interventions are excellent. Th e 
prevalence of decreased glomerular 
fi ltration rate (GFR; <60 ml/min × 
1.73 m2) increased with age; decreased 
GFR was greater than 30% for those aged 
75 years and older. Th ose with lower 
GFR had a higher reported incidence 
of renal disease. In addition, only 3% of 
those with a GFR less than 60 reported 
knowledge of having kidney disease. 
Th ese distressing results demonstrate 
that only patients with the most severe 
defects in kidney function were aware 
of the disease. Th ese fi ndings, similar to 
those in other populations, are a call to 
action to all nephrologists: we need to 
screen populations for chronic kidney 
disease and identify those who need 
early intervention. See page 800.
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